FI102895B1 - Menetelmä terapeuttisesti aktiivisten 5-(fenyylisulfonyyliamino)- ja 5-(fenyylisulfonyyliaminokarbonyyli)pyridiini-2-karboksyylihappoamidien valmistamiseksi - Google Patents

Menetelmä terapeuttisesti aktiivisten 5-(fenyylisulfonyyliamino)- ja 5-(fenyylisulfonyyliaminokarbonyyli)pyridiini-2-karboksyylihappoamidien valmistamiseksi

Info

Publication number
FI102895B1
FI102895B1 FI931250A FI931250A FI102895B1 FI 102895 B1 FI102895 B1 FI 102895B1 FI 931250 A FI931250 A FI 931250A FI 931250 A FI931250 A FI 931250A FI 102895 B1 FI102895 B1 FI 102895B1
Authority
FI
Finland
Prior art keywords
pyridine
phenylsulfonylaminocarbonyl
phenylsulfonylamino
preparation
carboxylic acid
Prior art date
Application number
FI931250A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI931250A (fi
FI931250A0 (fi
FI102895B (fi
Inventor
Klaus Weidmann
Martin Bickel
Volkmar Guenzler-Pukall
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI931250A0 publication Critical patent/FI931250A0/fi
Publication of FI931250A publication Critical patent/FI931250A/fi
Application granted granted Critical
Publication of FI102895B publication Critical patent/FI102895B/fi
Publication of FI102895B1 publication Critical patent/FI102895B1/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
FI931250A 1992-03-24 1993-03-22 Menetelmä terapeuttisesti aktiivisten 5-(fenyylisulfonyyliamino)- ja 5-(fenyylisulfonyyliaminokarbonyyli)pyridiini-2-karboksyylihappoamidien valmistamiseksi FI102895B1 (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4209424 1992-03-24
DE4209424 1992-03-24
DE4238506 1992-11-14
DE4238506 1992-11-14

Publications (4)

Publication Number Publication Date
FI931250A0 FI931250A0 (fi) 1993-03-22
FI931250A FI931250A (fi) 1993-09-25
FI102895B FI102895B (fi) 1999-03-15
FI102895B1 true FI102895B1 (fi) 1999-03-15

Family

ID=25913130

Family Applications (1)

Application Number Title Priority Date Filing Date
FI931250A FI102895B1 (fi) 1992-03-24 1993-03-22 Menetelmä terapeuttisesti aktiivisten 5-(fenyylisulfonyyliamino)- ja 5-(fenyylisulfonyyliaminokarbonyyli)pyridiini-2-karboksyylihappoamidien valmistamiseksi

Country Status (24)

Country Link
US (1) US5607954A (ru)
EP (1) EP0562512B1 (ru)
JP (1) JPH0649030A (ru)
KR (1) KR930019630A (ru)
CN (1) CN1076691A (ru)
AT (1) ATE199250T1 (ru)
AU (1) AU657608B2 (ru)
CA (1) CA2092276A1 (ru)
CZ (1) CZ46393A3 (ru)
DE (1) DE59310146D1 (ru)
DK (1) DK0562512T3 (ru)
ES (1) ES2154266T3 (ru)
FI (1) FI102895B1 (ru)
GR (1) GR3035479T3 (ru)
HK (1) HK1011987A1 (ru)
HU (2) HU219224B (ru)
MY (1) MY109143A (ru)
NO (1) NO179867C (ru)
NZ (1) NZ247201A (ru)
PL (1) PL173677B1 (ru)
PT (1) PT562512E (ru)
RU (1) RU2129545C1 (ru)
SK (1) SK280884B6 (ru)
TW (1) TW352384B (ru)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0650961B1 (de) * 1993-11-02 1997-03-05 Hoechst Aktiengesellschaft Substituierte heterocyclische Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
ES2101420T3 (es) * 1993-11-02 1997-07-01 Hoechst Ag Esteres-amidas de acidos carboxilicos heterociclicos sustituidos, su preparacion y su utilizacion como medicamentos.
NZ270267A (en) * 1993-12-30 1997-03-24 Hoechst Ag 3-hydroxypyridin-2yl (and -quinolin-2-yl) carboxamide derivatives and pharmaceutical compositions
DE4410453A1 (de) * 1994-03-25 1995-09-28 Hoechst Ag Substituierte heterocyclische Carbonsäureamidester, ihre Herstellung und ihre Verwendung als Arzneimittel
DE4410454A1 (de) * 1994-03-25 1995-09-28 Hoechst Ag Substituierte heterocyclische Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
DE4410480A1 (de) * 1994-03-25 1995-09-28 Hoechst Ag Sulfonamidocarbonylpyridin-2-carbonsäureesteramide sowie ihre Pyridin-N-oxide, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE4410423A1 (de) * 1994-03-25 1995-09-28 Hoechst Ag Sulfonamidocarbonylpyridin-2-carbonsäureamide sowie ihre Pyridin-N-oxide, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
IL135495A (en) * 1995-09-28 2002-12-01 Hoechst Ag Intermediate compounds for the preparation of quinoline-converted amines - 2 - carboxylic acid
DE19742951A1 (de) * 1997-09-29 1999-04-15 Hoechst Schering Agrevo Gmbh Acylsulfamoylbenzoesäureamide, diese enthaltende nutzpflanzenschützende Mittel und Verfahren zu ihrer Herstellung
DE19746287A1 (de) * 1997-10-20 1999-04-22 Hoechst Marion Roussel De Gmbh Substituierte Isochinolin-2-Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
AR015733A1 (es) 1998-03-25 2001-05-16 Otsuka Pharma Co Ltd DERIVADO DE PIRIDINA, EL PRODUCTO Y LA COMPOSICIoN FARMACEUTICA QUE CONTIENE DICHO DERIVADO.
US6583318B2 (en) 2001-05-17 2003-06-24 Advanced Syntech, Llc Method for synthesis of α-sulfonamido amide, carboxylic acid and hydroxamic acid derivatives
US20030176317A1 (en) 2001-12-06 2003-09-18 Volkmar Guenzler-Pukall Stabilization of hypoxia inducible factor (HIF) alpha
EP2295060B1 (en) 2001-12-06 2018-10-31 Fibrogen, Inc. Treatment or prevention of ischemic or hypoxic conditions
US7618940B2 (en) 2002-12-06 2009-11-17 Fibrogen, Inc. Fat regulation
US8124582B2 (en) 2002-12-06 2012-02-28 Fibrogen, Inc. Treatment of diabetes
US8614204B2 (en) 2003-06-06 2013-12-24 Fibrogen, Inc. Enhanced erythropoiesis and iron metabolism
CN101242817B (zh) 2005-06-15 2016-08-31 菲布罗根公司 HIF1α调节剂在治疗癌症中的用途
WO2007114612A1 (en) * 2006-03-30 2007-10-11 Lg Electronics Inc. A method and apparatus for decoding/encoding a video signal
EP3026044B8 (en) 2006-06-26 2018-12-19 Akebia Therapeutics, Inc. Prolyl hydroxylase inhibitors and methods of use
US8193194B2 (en) * 2007-05-25 2012-06-05 Vertex Pharmaceuticals Incorporated Ion channel modulators and methods of use
US8962530B2 (en) * 2007-06-27 2015-02-24 Regents Of The University Of Colorado Inflammatory bowel disease therapies
NO2686520T3 (ru) 2011-06-06 2018-03-17
EP2817292B1 (en) 2012-02-22 2019-12-18 Sanford-Burnham Medical Research Institute Sulfonamide compounds and uses as tnap inhibitors
TW201512171A (zh) 2013-04-19 2015-04-01 Pfizer Ltd 化學化合物
CN114404414A (zh) 2013-06-13 2022-04-29 阿克比治疗有限公司 用于治疗贫血症的组合物和方法
AR099354A1 (es) 2013-11-15 2016-07-20 Akebia Therapeutics Inc Formas sólidas de ácido {[5-(3-clorofenil)-3-hidroxipiridin-2-carbonil]amino}acético, composiciones, y sus usos
WO2016118858A1 (en) 2015-01-23 2016-07-28 Akebia Therapeutics, Inc. Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof
CN106146395B (zh) * 2015-03-27 2019-01-01 沈阳三生制药有限责任公司 3-羟基吡啶化合物、其制备方法及其制药用途
BR112017021097B1 (pt) 2015-04-01 2024-01-02 Akebia Therapeutics, Inc Formulação de dosagem oral e seu uso
TWI822776B (zh) 2018-05-09 2023-11-21 美商阿克比治療有限公司 用於製備2-[[5-(3-氯苯基)-3-羥基吡啶-2-羰基]胺基]乙酸之方法
US11524939B2 (en) 2019-11-13 2022-12-13 Akebia Therapeutics, Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid
CN111972405A (zh) * 2020-07-27 2020-11-24 南京太化化工有限公司 一种悬浮剂用助剂及异恶唑草酮悬浮剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3432094A1 (de) * 1984-08-31 1986-03-06 Hoechst Ag, 6230 Frankfurt Ester der pyridin-2,4- und -2,5- dicarbonsaeure als arzneimittel zur inhibierung der prolin- und lysinhydroxylase
US5153208A (en) * 1987-02-10 1992-10-06 Hoechst Aktiengesellschaft Pyridine-2,4- and -2,5-dicarboxylic acid amides and their medicinal compositions and methods of use
DE3703959A1 (de) * 1987-02-10 1988-08-18 Hoechst Ag Pyridin-2,4- und 2,5-dicarbonsaeureamide, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen
DE3703962A1 (de) * 1987-02-10 1988-08-18 Hoechst Ag Pyridin-2,4- und 2,5-dicarbonsaeure-derivate, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen
DE3928144A1 (de) * 1989-08-25 1991-02-28 Hoechst Ag Zyklische pyridin-2,4- und -2,5-dicarbonsaeurediamide, verfahren zu deren herstellung sowie deren verwendung
DE4020570A1 (de) * 1990-06-28 1992-01-02 Hoechst Ag 2,4- und 2,5-substituierte pyridin-n-oxide, verfahren zu deren herstellung sowie deren verwendung

Also Published As

Publication number Publication date
NZ247201A (en) 1996-05-28
DK0562512T3 (da) 2001-03-19
FI931250A (fi) 1993-09-25
PT562512E (pt) 2001-06-29
FI931250A0 (fi) 1993-03-22
RU2129545C1 (ru) 1999-04-27
SK22393A3 (en) 1993-10-06
AU3536993A (en) 1993-09-30
HU210714A9 (en) 1995-06-28
EP0562512B1 (de) 2001-02-21
HU219224B (en) 2001-03-28
CA2092276A1 (en) 1993-09-25
HK1011987A1 (en) 1999-07-23
AU657608B2 (en) 1995-03-16
MY109143A (en) 1996-12-31
US5607954A (en) 1997-03-04
NO179867C (no) 1997-01-02
EP0562512A1 (de) 1993-09-29
FI102895B (fi) 1999-03-15
HU9300850D0 (en) 1993-06-28
DE59310146D1 (de) 2001-03-29
PL298195A1 (en) 1994-01-10
ATE199250T1 (de) 2001-03-15
NO179867B (no) 1996-09-23
CZ46393A3 (en) 1994-01-19
NO931056D0 (no) 1993-03-23
KR930019630A (ko) 1993-10-18
GR3035479T3 (en) 2001-05-31
CN1076691A (zh) 1993-09-29
JPH0649030A (ja) 1994-02-22
NO931056L (no) 1993-09-27
SK280884B6 (sk) 2000-09-12
HUT69685A (en) 1995-09-28
ES2154266T3 (es) 2001-04-01
PL173677B1 (pl) 1998-04-30
TW352384B (en) 1999-02-11

Similar Documents

Publication Publication Date Title
FI102895B1 (fi) Menetelmä terapeuttisesti aktiivisten 5-(fenyylisulfonyyliamino)- ja 5-(fenyylisulfonyyliaminokarbonyyli)pyridiini-2-karboksyylihappoamidien valmistamiseksi
ES8705387A1 (es) Un procedimiento para preparar derivados de n-aril-n-(4-piperidinil)-alcoxialquilamida
ES2113413T3 (es) Derivados antiviricos del acido 2-desoxi-2,3-didehidro alfa-d-neuraminico 4 substituido.
ES2102132T3 (es) Amidas de acidos carboxilicos heterociclicos sustituidos, su preparacion y su utilizacion como medicamentos.
ES2052065T3 (es) Formulacion dispersable.
DK0612731T3 (da) Nye quinolon- og naphthyridoncarboxylsyrederivater
NO180334C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive difluorstatonanaloger
TNSN89016A1 (fr) Procede pour la preparation d'esters d'acide cepheme - carboxylique
EP0457090A3 (en) Process for the preparation of 3-amino-2 (het)aroyl-acrylic acid derivatives
ES2054089T3 (es) Formulaciones orales liquidas.
FI934303A0 (fi) Acylsulfonamido- och sulfonamidopyridin-2-karboxylsyraestrar och deraspyridin-n-oxider, foerfarande foer deras framstaellning och deras anvaendning som laekemedel
SE8503109L (sv) Cykliska forstadielekemedel till antiinflammatoriska oxikamer
DE59307401D1 (de) Alpha-Aryl-alpha-hydroxy-beta-imidazolinylpropionsäureamide
GR3015937T3 (en) Salts of the 2-(2,6-dichloroanilino)-phenylacetic acid, process for their preparation and their application as pharmaceutical preparations for topical use.
IT1241515B (it) Sali dell'acido nicotinico con composti aminobenzilici e loro impiego farmaceutico".
IT8021053A0 (it) Ammidi dell'acido teofillin-7-acetico, procedimenti per la loro preparazione e relative composizioni farmaceutiche.
IT8948511A0 (it) Nuovi sali dell'acido nicotinico con composti aminobenzilici e loro impiego farmaceutico.
IT8221556A0 (it) Ammidi dell'acido teofillin-7-acetico, procedimenti per la loro preparazione e relative composizioni farmaceutiche.
IT7827749A0 (it) Ammidi dell'acido di-tio-salicilico alchilate basiche, procedimento per la loro preparazione e loro impiego come prodotti medicinali.